SFShaun Frost

Shaun Frost

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Shaun Frost has a total of 144 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Default Mode Network Detection using EEG in Real-time

    by Navin Cooray, Chetan Gohil, Brendan Harris, Shaun Frost, Cameron Higgins

    Mental health disorders affect countless people worldwide and present a major challenge for mental health services, which are struggling with the demand on a global scale. Recent studies have indicated that activity of the brain’s Default Mode Network (DMN) could prove insightful in monitoring patient recovery from depression and has been used as a therapeutic target itself. An opportunity exists to replicate recent therapeutic protocols targeting DMN connectivity via functional magnetic resonance imaging using the more economically scalable modality of electroencephalogram (EEG). The aim of this work was to validate the accuracy of real-time DMN detection methods applied to EEG data, using a publicly available dataset. Using a Hidden Markov Model to identify a 12-state resting-state network, this work achieved an overall DMN detection accuracy of 95%. Furthermore, the model was able to achieve a correlation of 0.617 between the baseline and calculated DMN fractional occupancy. These results demonstrate the ability of real-time analysis to effectively identify the DMN through EEG data providing an avenue for further applications that monitor and treat mental health disorders.


  • Understanding and interpreting CNN's decision in optical coherence tomography-based AMD detection

    by S. M. Azoad Ahnaf, Sajib Saha, Shaun Frost, G. M. Atiqur Rahaman

    Introduction: Automated assessment of age-related macular degeneration (AMD) using optical coherence tomography (OCT) has gained significant research attention in recent years. Though a list of convolutional neural network (CNN)-based methods has been proposed recently, methods that uncover the decision-making process of CNNs or critically interpret CNNs’ decisions in the context are scant. This study aims to bridge this research gap. Methods: We independently trained several state-of-the-art CNN models, namely, VGG16, VGG19, Xception, ResNet50, InceptionResNetV2 for AMD detection and applied CNN visualization techniques, namely, Grad-CAM, Grad-CAM++, Score CAM, Faster Score CAM to highlight the regions of interest utilized by the CNNs in the context. Retinal layer segmentation methods were also developed to explore how the CNN regions of interest related to the layers of the retinal structure. Extensive experiments involving 2130 SD-OCT scans collected from Duke University were performed. Results: Experimental analysis shows that Outer Nuclear Layer to Inner Segment Myeloid (ONL-ISM) influences the AMD detection decision heavily as evident from the normalized intersection (NI) scores. For AMD cases the obtained average NI scores were respectively 13.13%, 17.2%, 9.7%, 10.95%, and 11.31% for VGG16, VGG19, ResNet50, Xception, and Inception ResNet V2, whereas, for normal cases, these values were respectively 21.7%, 21.3%, 16.85%, 10.175% and 16%. Conclusion: Critical analysis reveals that the ONL-ISM is the most contributing layer in determining AMD, followed by Nerve Fiber Layer to Inner Plexiform Layer (NFL-IPL).


  • Open Access

    The Longitudinal Assessment of Vascular Parameters of the Retina and Their Correlations with Systemic Characteristics in Type 2 Diabetes—A Pilot Study

    by Rehana Khan, Sajib K Saha, Shaun Frost, Yogesan Kanagasingam, Rajiv Raman

    The aim of the study was to assess various retinal vessel parameters of diabetes mellitus (DM) patients and their correlations with systemic factors in type 2 DM. A retrospective exploratory study in which 21 pairs of baseline and follow-up images of patients affected by DM were randomly chosen from the Sankara Nethralaya–Diabetic Retinopathy Study (SN DREAMS) I and II datasets. Patients’ fundus was photographed, and the diagnosis was made based on Klein classification. Vessel thickness parameters were generated using a web-based retinal vascular analysis platform called VASP. The thickness changes between the baseline and follow-up images were computed and normalized with the actual thicknesses of baseline images. The majority of parameters showed 10~20% changes over time. Vessel width in zone C for the second vein was significantly reduced from baseline to follow-up, which showed positive correlations with systolic blood pressure and serum high-density lipoproteins. Fractal dimension for all vessels in zones B and C and fractal dimension for vein in zones A, B and C showed a minimal increase from baseline to follow-up, which had a linear relationship with diastolic pressure, mean arterial pressure, serum triglycerides (p < 0.05). Lacunarity for all vessels and veins in zones A, B and C showed a minimal decrease from baseline to follow-up which had a negative correlation with pulse pressure and positive correlation with serum triglycerides (p < 0.05). The vessel widths for the first and second arteries significantly increased from baseline to follow-up and had an association with high-density lipoproteins, glycated haemoglobin A1C, serum low-density lipoproteins and total serum cholesterol. The central reflex intensity ratio for the second artery was significantly decreased from baseline to follow-up, and positive correlations were noted with serum triglyceride, serum low-density lipoproteins and total serum cholesterol. The coefficients for branches in zones B and C artery and the junctional exponent deviation for the artery in zone A decreased from baseline to follow-up showed positive correlations with serum triglycerides, serum low-density lipoproteins and total serum cholesterol. Identifying early microvascular changes in diabetic patients will allow for earlier intervention, improve visual outcomes and prevent vision loss.


  • Open Access

    Retinal capillary rarefaction is associated with arterial and kidney damage in hypertension

    by Shaun Frost, Janis Marc Nolde, Justine Chan, Anu Joyson, Cynthia Gregory, Revathy Carnagarin, Lakshini Y. Herat, Vance B. Matthews, Liam Robinson, Janardhan Vignarajan, et al.

    Microvascular disease and rarefaction are key pathological hallmarks of hypertension. The retina uniquely allows direct, non-invasive investigation of the microvasculature. Recently developed optical coherence tomography angiography now allows investigation of the fine retinal capillaries, which may provide a superior marker of overall vascular damage. This was a prospective cross-sectional study to collect retinal capillary density data on 300 normal eyes from 150 hypertensive adults, and to investigate possible associations with other organ damage markers. The average age of participants was 54 years and there was a greater proportion of males (85; 57%) than females. Multivariate, confounder adjusted linear regression showed that retinal capillary rarefaction in the parafovea was associated with increased pulse wave velocity (β = − 0.4,P = 0.04), log-albumin/creatinine ratio (β = − 0.71,P = 0.003), and with reduced estimated glomerular filtration rate (β = 0.04,P = 0.02). Comparable significant associations were also found for whole-image vascular-density, for foveal vascular-density significant associations were found with pulse wave velocity and estimated glomerular filtration rate only. Our results indicate that retinal capillary rarefaction is associated with arterial stiffness and impaired kidney function. Retinal capillary rarefaction may represent a useful and simple test to assess the integrated burden of hypertension on the microvasculature irrespective of current blood pressure levels.


  • Effect of Pupil Dilation with Tropicamide on Retinal Vascular Caliber

    by Shaun Frost, Cynthia Gregory, Liam Robinson, Shuang Yu, Di Xiao, Maryam Mehdizadeh, Samantha Burnham, Cirous Dehghani, Janardhan Vignarajan, Yogesan Kanagasingam, et al.

    Purpose: The retinal blood vessels reflect changes in the brain’s micro-circulation and these changes have been shown to correlate with the incidence of diseases such as stroke, heart disease and Alzheimer’s disease. Studies investigating the retinal vasculature routinely use pupil dilation with tropicamide to optimize image acquisition and quality. The aim of this study was to investigate the effects of tropicamide on retinal vascular parameters using retinal photography. Methods: The study was performed on 41 healthy young subjects of both sexes, using tropicamide to dilate only the right pupil, leaving the left as a control. Results: Pupil dilation with tropicamide resulted in reduced retinal vessel width measures based on standardized approaches, particularly reduced arteriolar caliber (p < .0005). However, closer investigation of the images revealed reduced fundus image magnification in the post-tropicamide images, based on reduced optic nerve head diameter (p < .0005) and longitudinal analysis with image registration and affine transformation (p < .0001). No change in vessel width parameters was observed after adjustment for image magnification. Conclusion: These results suggest that tropicamide does not change the width of the retinal vessels, however width parameters as measured by standard approaches may be reduced due to image magnification changes resulting from cycloplegia. In this study, improved optic nerve head segmentation for image scale conversion removed the magnification error. With this correction, the tropicamide intervention had no effect on vessel width parameters in young healthy people and could be utilized in future without affecting the results of retinal vascular analysis.


  • Open Access

    Ocular Biomarkers of Alzheimer's Disease: The Role of Anterior Eye and Potential Future Directions

    by Cirous Dehghani, Shaun Frost, Rajiv Jayasena, Colin L. Masters, Yogesan Kanagasingam

    Globally, Alzheimer's disease (AD) is a growing health and economic challenge that has no effective cure. Recent clinical trials indicate that preclinical treatment may be required but a routine screening tool for AD has been elusive. Hence, a simple, yet sensitive biomarker for preclinical AD, when the disease is most likely to be amenable to treatment, is lacking. Due to several features, the eye has been explored for this purpose and, among the ocular tissues, the retina has received the most attention. Currently, major works investigating the potential AD diagnosis by detecting amyloid-β (Aβ) signatures in the retinal tissue are underway, while the anterior eye is more accessible for in vivo imaging and examination. This report provides a concise review of current literature on the anterior eye components, including the crystalline lens, cornea, and aqueous humor, in AD. We also discuss the potential for assessment of the corneal nerve structure and regeneration as well as conjunctival tissue for AD-related alterations. The crystalline lens has received considerable attention, but further research is required to confirm whether Aβ accumulates in the lens and whether it mirrors brain neuropathologic changes, particularly in preclinical AD. The rich corneal neural network and conjunctival vasculature also merit exploration in future studies to shed light on their potential association with AD pathologic changes.


  • Open Access

    Alzheimer’s Disease: A Journey from Amyloid Peptides and Oxidative Stress, to Biomarker Technologies and Disease Prevention Strategies—Gains from AIBL and DIAN Cohort Studies

    by Ralph N. Martins, Victor Villemagne, Hamid R. Sohrabi, Pratishtha Chatterjee, Tejal M. Shah, Giuseppe Verdile, Paul Fraser, Kevin Taddei, Veer B. Gupta, Stephanie R. Rainey-Smith, et al.

    Worldwide there are over 46 million people living with dementia, and this number is expected to double every 20 years reaching about 131 million by 2050. The cost to the community and government health systems, as well as the stress on families and carers is incalculable. Over three decades of research into this disease have been undertaken by several research groups in Australia, including work by our original research group in Western Australia which was involved in the discovery and sequencing of the amyloid-β peptide (also known as Aβ or A4 peptide) extracted from cerebral amyloid plaques. This review discusses the journey from the discovery of the Aβ peptide in Alzheimer’s disease (AD) brain to the establishment of pre-clinical AD using PET amyloid tracers, a method now serving as the gold standard for developing peripheral diagnostic approaches in the blood and the eye. The latter developments for early diagnosis have been largely achieved through the establishment of the Australian Imaging Biomarker and Lifestyle research group that has followed 1,100 Australians for 11 years. AIBL has also been instrumental in providing insight into the role of the major genetic risk factor apolipoprotein E ɛ4, as well as better understanding the role of lifestyle factors particularly diet, physical activity and sleep to cognitive decline and the accumulation of cerebral Aβ.


  • Performance Evaluation of State-of-the-Art Local Feature Detectors and Descriptors in the Context of Longitudinal Registration of Retinal Images

    by Sajib K. Saha, Di Xiao, Shaun Frost, Yogesan Kanagasingam

    In this paper we systematically evaluate the performance of several state-of-the-art local feature detectors and descriptors in the context of longitudinal registration of retinal images. Longitudinal (temporal) registration facilitates to track the changes in the retina that has happened over time. A wide number of local feature detectors and descriptors exist and many of them have already applied for retinal image registration, however, no comparative evaluation has been made so far to analyse their respective performance. In this manuscript we evaluate the performance of the widely known and commonly used detectors such as Harris, SIFT, SURF, BRISK, and bifurcation and cross-over points. As of descriptors SIFT, SURF, ALOHA, BRIEF, BRISK and PIIFD are used. Longitudinal retinal image datasets containing a total of 244 images are used for the experiment. The evaluation reveals some potential findings including more robustness of SURF and SIFT keypoints than the commonly used bifurcation and cross-over points, when detected on the vessels. SIFT keypoints can be detected with a reliability of 59% for without pathology images and 45% for with pathology images. For SURF keypoints these values are respectively 58% and 47%. ALOHA descriptor is best suited to describe SURF keypoints, which ensures an overall matching accuracy, distinguishability of 83%, 93% and 78%, 83% for without pathology and with pathology images respectively.


  • Modulation of Retinal Arteriolar Central Reflection by APOE Genotype

    by Shaun Frost, Alauddin Bhuiyan, David Offerman, James D. Doecke, S. Lance Macaulay, Hamid R. Sohrabi, David Ames, Colin Masters, Ralph N. Martins, Yogesan Kanagasingam, et al.

    Objective: This study investigated the retinal arteriolar central reflex (CR, the central reflection observed in photographs of retinal vessels), which may provide information about micro-vascular health in the retina and also the brain, due to the homology between these vascular networks. The study also describes a novel computer based semi-automated technique that accurately quantifies retinal arteriolar CR and vessel width, and calculates the CR to vessel width ratio (CRR) from digital retinal photographs. Methods: Digital retinal photographs were collected from participants in the Australian Imaging, Biomarkers and Lifestyle study of ageing (AIBL), including 25 participants diagnosed with Alzheimer’s disease (AD) (age 72.4 ± 7.5 yrs, 12 male, 13 female) and 123 elderly participants without dementia (cognitively normals: CN) (age 71.6 ± 5.6 yrs, 55 male, 68 female). Using a sub-cohort of 144 (22 AD, 122 CN) with the novel CRR measures, we identified significantly higher CRR levels in AD participants (mean CRR 0.253 (SD 0.04)) as compared with CN’s (mean CRR 0.231 (SD 0.04), p = 0.025). Adjustment for APOE ε4 allele status however, reduced the significance (p = 0.081). CRR was significantly higher in APOE ε4 allele carriers (mean CRR 0.254 (SD 0.03) as compared with non-carriers (mean CRR 0.224 (SD 0.05), p < 0.0001). Results: These data indicate that CRR is strongly linked to APOE ε4 status and exhibits a weaker, independent trend with AD diagnosis. The retina may be useful as a novel model for non-invasive monitoring of the effects of APOE ε4 on the central nervous system, particularly in cerebrovascular disease.